RedHill Biopharma Launches Phase 2 Trial For Advanced Prostate Cancer Treatment
(RTTNews) - RedHill Biopharma (RDHL) Tuesday announced that it has launched a Phase 2 trial to assess opaganib's ability to enhance darolutamide in treating metastatic castrate-resistant prostate ...
Arkansas Catholic8h
St. Bernards Medical Center offers Arkansas’ first noninvasive prostate cancer treatment
Arkansas' first noninvasive treatment of early-stage prostate cancer was successfully performed at St. Bernards Medical Center, reducing risks and side effects.
healthday11h
Improvements in Prostate Cancer Mortality Plateaued From 2012 to 2021
Distant-stage prostate cancer increased and mortality rates plateaued throughout California during the 2010s, accordin ...
RedHill Biopharma Ltd.: RedHill Announces Initiation of Phase 2 Study of Opaganib and Darolutamide in Advanced Prostate Cancer
The 80-patient placebo-controlled randomized Phase 2 study will evaluate the efficacy of opaganib in combination with Bayer's darolutamide in men with metastatic castrate-resistant ...
RedHill Announces Initiation of Phase 2 Study of Opaganib and Darolutamide in Advanced Prostate Cancer
RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced ...
‘Significant milestone’: Non-invasive prostate cancer treatment introduced at SIUH
Northwell Staten Island University Hospital has announced the addition of the Focal One High-Intensity Focused Ultrasound ...